CD8A and neoplasm: However, despite being increased in size, tumours at Day 31 in IL4‐treated C26 hosts present with conspicuous necrotic areas and with a high number of infiltrating inflammatory/immune cells (CD8+ lymphocytes and type II macrophages), which could be involved in tumour cytotoxicity and necrosis.